Page 2 - Invivo Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jeito Capital Co-leads EUR 65 Million (USD 71 M) Financing in Corteria Pharmaceuticals, a French Biopharmaceutical Company Developing Novel Treatments for Cardiovascular Diseases

Jeito Capital Co-leads EUR 65 Million (USD 71 M) Financing in Corteria Pharmaceuticals, a French Biopharmaceutical Company Developing Novel Treatments for Cardiovascular Diseases
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalAssia mouhoutJeito capitaladdedAndreas wallnoeferMarie laure ozouxPhilip janiakCorteria pharmaceuticalsConsilium strategic communicationsBanque de franceKorea bizwireJeito capitalKurma partnersFountain healthcare partnersV bio venturesInvivo capital

EQS-PVR: Corestate Capital Holding S A : notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers

EQS-PVR: Corestate Capital Holding S A : notification of a change in major holdings pursuant to the modified law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Rue jean monnetNews serviceCorestate capital holdingDistribution servicesRights announcementVoting rights announcementGrand ducal regulationJean monnetInvivo capitalFinancial instrumentsTransparency lawRegulatory announcementsCorporate newsAktien sie

EIT Health: Arthex Biotech closes €42M Series B financing round

EIT Health-supported start-up, Arthex Biotech, has successfully closed a €42 million Series B financing round. Prior to attracting these funds, the Valencia-based clinical-stage biotech start-up received an EIC accelerator grant, having been fast-tracked through our support.

Beatriz llamusEuropean innovation councilHealth fastCentre for the development of industrial technologyArthex biotechColumbus venture partnersHadean venturesSound bioventuresInvivo capitalAdbio partnersIndustrial technologyMyotonic dystrophy typeFast track

ARTHEx Biotech Announces Closing of €42 M Series B Financing to Advance ATX-01, its Novel Treatment for Myotonic Dystrophy Type 1 (DM1)

/PRNewswire/ ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs.

France generalJose mesaBeatriz llamusAmy conradCompany contactEuropean innovation councilUniversity of parisBusiness schoolCorporate head of business development valnevaCentre for the development of industrial technologyColumbus venture partnersHadean venturesSound bioventuresInvivo capitalAdbio partnersIndustrial technology

ARTHEx Biotech Closes €42M Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Centre for the development of industrial technologyEuropean innovation councilColumbus venture partnersHadean venturesSound bioventuresInvivo capitalAdbio partnersChief executiveMyotonic dystrophy type